The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses (original) (raw)

• Walker, L. S. & Abbas, A. K. The enemy within: keeping self-reactive T cells at bay in the periphery. Nature Rev. Immunol. 2, 11–19 (2002).
  CAS Google Scholar
• Brunkow, M. E. et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nature Genet. 27, 68–73 (2001).
  CAS PubMed Google Scholar
• Wahl, S. M., Orenstein, J. M. & Chen, W. TGF-β influences the life and death decisions of T lymphocytes. Cytokine Growth Factor Rev. 11, 71–79 (2000).
  CAS PubMed Google Scholar
• Fehervari, Z., Yamaguchi, T. & Sakaguchi, S. The dichotomous role of IL-2: tolerance versus immunity. Trends Immunol. 27, 109–111 (2006).
  CAS PubMed Google Scholar
• Tivol, E. A. et al. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3, 541–547 (1995).
  CAS PubMed Google Scholar
• Waterhouse, P. et al. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270, 985–988 (1995). References 5 and 6 were the first reports of the lethal lymphoproliferative syndrome that occurs in CTLA4-deficient mice, demonstrating the central role of this molecule in the regulation of T cell immune responses.
  CAS PubMed Google Scholar
• Chambers, C. A., Sullivan, T. J. & Allison, J. P. Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation-dependent activation of CD4+ cells. Immunity 7, 885–895 (1997). This report shows that depletion of CD4+ T cells prevents lymphocytic infiltration of peripheral tissues in CTLA4-deficient mice, illustrating the role of CTLA4 in CD4+ T cell function.
  CAS PubMed Google Scholar
• Leach, D. R., Krummel, M. F. & Allison, J. P. Enhancement of antitumor immunity by CTLA-4 blockade. Science 271, 1734–1736 (1996).
  CAS PubMed Google Scholar
• Peggs, K. S., Quezada, S. A., Korman, A. J. & Allison, J. P. Principles and use of anti-CTLA4 antibody in human cancer immunotherapy. Curr. Opin. Immunol. 18, 206–213 (2006).
  CAS PubMed Google Scholar
• Ueda, H. et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423, 506–511 (2003).
  CAS PubMed Google Scholar
• Vijayakrishnan, L. et al. An autoimmune disease-associated CTLA-4 splice variant lacking the B7 binding domain signals negatively in T cells. Immunity 20, 563–575 (2004).
  CAS PubMed Google Scholar
• Gough, S. C., Walker, L. S. & Sansom, D. M. CTLA4 gene polymorphism and autoimmunity. Immunol. Rev. 204, 102–115 (2005).
  CAS PubMed Google Scholar
• Sansom, D. M. CD28, CTLA-4 and their ligands: who does what and to whom? Immunology 101, 169–177 (2000).
  CAS PubMed PubMed Central Google Scholar
• Sansom, D. M., Manzotti, C. N. & Zheng, Y. What's the difference between CD80 and CD86? Trends Immunol. 24, 313–318 (2003).
  Google Scholar
• Sansom, D. M. & Walker, L. S. The role of CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA-4) in regulatory T-cell biology. Immunol. Rev. 212, 131–148 (2006).
  CAS PubMed Google Scholar
• Keir, M. E. & Sharpe, A. H. The B7/CD28 costimulatory family in autoimmunity. Immunol. Rev. 204, 128–143 (2005).
  CAS PubMed Google Scholar
• Linsley, P. S. et al. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J. Exp. Med. 173, 721–730 (1991).
  CAS PubMed Google Scholar
• Thompson, C. et al. CD28 activation pathway regulates the production of multiple T cell-derived lymphokines/cytokines. Proc. Natl Acad. Sci. USA 86, 1333–1337 (1993).
  Google Scholar
• Boise, L. H. et al. CD28 costimulation can promote T cell survival by enhancing expression of Bcl-XL . Immunity 3, 87–98 (1995).
  CAS PubMed Google Scholar
• McLeod, J. D. et al. Activation of human T cells with superantigen and CD28 confers resistance to apoptosis by CD95. J. Immunol. 160, 2072–2079 (1998).
  CAS PubMed Google Scholar
• Ferguson, S. E., Han, S., Kelsoe, G. & Thompson, C. B. CD28 is required for germinal center formation. J. Immunol. 156, 4576–4581 (1996).
  CAS PubMed Google Scholar
• Iezzi, G., Karjalainen, K. & Lanzavecchia, A. The duration of antigenic stimulation determines the fate of naive and effector T cells. Immunity 8, 89–95 (1998).
  CAS PubMed Google Scholar
• Gett, A. V. & Hodgkin, P. D. A cellular calculus for signal integration by T cells. Nature Immunol. 1, 239–244 (2000).
  CAS Google Scholar
• Shahinian, A. et al. Differential T cell costimulatory requirements in CD28-deficient mice. Science 261, 609–612 (1993).
  Article CAS PubMed Google Scholar
• Walker, L. S., Gulbranson-Judge, A., Flynn, S., Brocker, T. & Lane, P. J. Co-stimulation and selection for T-cell help for germinal centres: the role of CD28 and OX40. Immunol. Today 21, 333–337 (2000).
  CAS PubMed Google Scholar
• Walunas, T. L. et al. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1, 405–413 (1994).
  CAS PubMed Google Scholar
• Krummel, M. F. & Allison, J. P. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182, 459–465 (1995).
  CAS PubMed Google Scholar
• Kearney, E. R. et al. Antigen-dependent clonal expansion of a trace population of antigen-specific CD4+ T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4. J. Immunol. 155, 1032–1036 (1995).
  CAS PubMed Google Scholar
• Hurwitz, A. A., Sullivan, T. J., Sobel, R. A. & Allison, J. P. Cytotoxic T lymphocyte antigen-4 (CTLA-4) limits the expansion of encephalitogenic T cells in experimental autoimmune encephalomyelitis (EAE)-resistant BALB/c mice. Proc. Natl Acad. Sci. USA 99, 3013–3017 (2002).
  CAS PubMed PubMed Central Google Scholar
• Collins, A. V. et al. The interaction properties of costimulatory molecules revisited. Immunity 17, 201–210 (2002).
  CAS PubMed Google Scholar
• Lenschow, D. J. et al. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg. Science 257, 789–792 (1992).
  CAS PubMed Google Scholar
• Linsley, P. S. et al. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science 257, 792–795 (1992).
  CAS PubMed Google Scholar
• Tivol, E. A. et al. CTLA4Ig prevents lymphoproliferation and fatal multiorgan tissue destruction in CTLA-4-deficient mice. J. Immunol. 158, 5091–5094 (1997).
  CAS PubMed Google Scholar
• Mandelbrot, D. A., McAdam, A. J. & Sharpe, A. H. B7–1 or B7–2 is required to produce the lymphoproliferative phenotype in mice lacking cytotoxic T lymphocyte-associated antigen 4 (CTLA-4). J. Exp. Med. 189, 435–440 (1999).
  CAS PubMed PubMed Central Google Scholar
• Tai, X., Van Laethem, F., Sharpe, A. H. & Singer, A. Induction of autoimmune disease in CTLA-4−/− mice depends on a specific CD28 motif that is required for in vivo costimulation. Proc. Natl Acad. Sci. USA 104, 13756–13761 (2007). This study identified the C-terminal proline residues of CD28 that are required to cause the lymphoproliferative syndrome associated with CTLA4 deficiency. This emphasizes that the central role of CTLA4 is to inhibit the CD28 pathway.
  CAS PubMed PubMed Central Google Scholar
• Linsley, P. S. et al. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes. J. Exp. Med. 176, 1595–1604 (1992).
  CAS PubMed Google Scholar
• Metzler, B., Burkhart, C. & Wraith, D. C. Phenotypic analysis of CTLA-4 and CD28 expression during transient peptide-induced T cell activation in vivo. Int. Immunol. 11, 667–675 (1999).
  CAS PubMed Google Scholar
• Read, S., Malmstrom, V. & Powrie, F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25+CD4+ regulatory cells that control intestinal inflammation. J. Exp. Med. 192, 295–302 (2000).
  CAS PubMed PubMed Central Google Scholar
• Takahashi, T. et al. Immunologic self-tolerance maintained by CD25+CD4+ regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192, 303–310 (2000). References 38 and 39 provided the first evidence for a role for CTLA4 in T Reg cell function.
  CAS PubMed PubMed Central Google Scholar
• Mead, K. I. et al. Exocytosis of CTLA-4 is dependent on phospholipase D and ADP ribosylation factor-1 and stimulated during activation of regulatory T cells. J. Immunol. 174, 4803–4811 (2005).
  CAS PubMed Google Scholar
• Manzotti, C. N. et al. Integration of CD28 and CTLA-4 function results in differential responses of T cells to CD80 and CD86. Eur. J. Immunol. 36, 1413–1422 (2006).
  CAS PubMed Google Scholar
• Linsley, P. S. et al. Intracellular trafficking of CTLA-4 and focal localisation towards sites of TCR engagement. Immunity 4, 535–543 (1996). This study shows that CTLA4 is an intracellular protein that is stimulated to traffic to TCR contact sites.
  CAS PubMed Google Scholar
• Shiratori, T. et al. Tyrosine phosphorylation controls internalization of CTLA-4 by regulating its interaction with clathrin-associated adaptor complex AP-2. Immunity 6, 583–589 (1997). This work demonstrates the association of CTLA4 with the clathrin-associated adaptor complex AP2, which underpins its endocytic behaviour.
  CAS PubMed Google Scholar
• Chuang, E. et al. Interaction of CTLA-4 with the clathrin-associated protein AP50 results in ligand-independent endocytosis that limits cell surface expression. J. Immunol. 159, 144–151 (1997).
  CAS PubMed Google Scholar
• Zhang, Y. & Allison, J. P. Interaction of CTLA-4 with AP-50, a clathrin-coated pit adaptor protein. Proc. Natl Acad. Sci. USA 94, 9273–9278 (1997).
  CAS PubMed PubMed Central Google Scholar
• Schneider, H. et al. Cytolytic T lymphocyte-associated antigen-4 and the TCRζ/CD3 complex, but not CD28, interact with clathrin adaptor complexes AP-1 and AP-2. J. Immunol. 163, 1868–1879 (1999).
  CAS PubMed Google Scholar
• Egen, J. G. & Allison, J. P. Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength. Immunity 16, 23–35 (2002). This study shows that TCR stimulation causes accumulation of CTLA4 at the immune synapse.
  CAS PubMed Google Scholar
• Qureshi, O. S. et al. _Trans_-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. Science 332, 600–603 (2011).
  CAS PubMed PubMed Central Google Scholar
• Iida, T. et al. Regulation of cell surface expression of CTLA-4 by secretion of CTLA-4-containing lysosomes upon activation of CD4+ T cells. J. Immunol. 165, 5062–5068 (2000).
  CAS PubMed Google Scholar
• Wu, Y. et al. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 126, 375–387 (2006).
  CAS PubMed Google Scholar
• Gavin, M. A. et al. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 445, 771–775 (2007).
  CAS PubMed Google Scholar
• Thornton, A. M. & Shevach, E. M. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188, 287–296 (1998).
  CAS PubMed PubMed Central Google Scholar
• Tang, Q. et al. Distinct roles of CTLA-4 and TGF-β in CD4+CD25+ regulatory T cell function. Eur. J. Immunol. 34, 2996–3005 (2004).
  CAS PubMed Google Scholar
• Manzotti, C. N. et al. Inhibition of human T cell proliferation by CTLA-4 utilizes CD80 and requires CD25+ regulatory T cells. Eur. J. Immunol. 32, 2888–2896 (2002).
  CAS PubMed Google Scholar
• Zheng, Y. et al. Acquisition of suppressive function by activated human CD4+ CD25− T cells is associated with the expression of CTLA-4 not FoxP3. J. Immunol. 181, 1683–1691 (2008).
  CAS PubMed Google Scholar
• Kataoka, H. et al. CD25+CD4+ regulatory T cells exert in vitro suppressive activity independent of CTLA-4. Int. Immunol. 17, 421–427 (2005). This study demonstrates that suppression by wild-type T Reg cells is CTLA4 dependent, but that alternative mechanisms can allow CTLA4-deficient cells to suppress immune responses.
  CAS PubMed Google Scholar
• Quezada, S. A., Peggs, K. S., Curran, M. A. & Allison, J. P. CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells. J. Clin. Invest. 116, 1935–1945 (2006).
  CAS PubMed PubMed Central Google Scholar
• Kavanagh, B. et al. CTLA4 blockade expands FoxP3+ regulatory and activated effector CD4+ T cells in a dose-dependant fashion. Blood 112, 1175–1183 (2008).
  CAS PubMed PubMed Central Google Scholar
• Schmidt, E. M. et al. CTLA-4 controls regulatory T cell peripheral homeostasis and is required for suppression of pancreatic islet autoimmunity. J. Immunol. 182, 274–282 (2009).
  CAS PubMed Google Scholar
• Verhagen, J. et al. Enhanced selection of FoxP3+ T-regulatory cells protects CTLA-4-deficient mice from CNS autoimmune disease. Proc. Natl Acad. Sci. USA 106, 3306–3311 (2009).
  CAS PubMed PubMed Central Google Scholar
• Wing, K. et al. CTLA-4 control over Foxp3+ regulatory T cell function. Science 322, 271–275 (2008).
  CAS PubMed Google Scholar
• Read, S. et al. Blockade of CTLA-4 on CD4+CD25+ regulatory T cells abrogates their function in vivo. J. Immunol. 177, 4376–4383 (2006).
  CAS PubMed Google Scholar
• Sojka, D. K., Hughson, A. & Fowell, D. J. CTLA-4 is required by CD4+CD25+ Treg to control CD4+ T-cell lymphopenia-induced proliferation. Eur. J. Immunol. 39, 1544–1551 (2009).
  CAS PubMed PubMed Central Google Scholar
• Kolar, P. et al. CTLA-4 (CD152) controls homeostasis and suppressive capacity of regulatory T cells in mice. Arthritis Rheum. 60, 123–132 (2009).
  CAS PubMed Google Scholar
• Ise, W. et al. CTLA-4 suppresses the pathogenicity of self antigen-specific T cells by cell-intrinsic and cell-extrinsic mechanisms. Nature Immunol. 11, 129–135 (2010).
  CAS Google Scholar
• Jain, N., Nguyen, H., Chambers, C. & Kang, J. Dual function of CTLA-4 in regulatory T cells and conventional T cells to prevent multiorgan autoimmunity. Proc. Natl Acad. Sci. USA 107, 1524–1528 (2010).
  CAS PubMed PubMed Central Google Scholar
• Rubtsov, Y. P. et al. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 28, 546–558 (2008).
  CAS PubMed Google Scholar
• Tang, Q. & Bluestone, J. A. The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nature Immunol. 9, 239–244 (2008).
  CAS Google Scholar
• Vignali, D. A., Collison, L. W. & Workman, C. J. How regulatory T cells work. Nature Rev. Immunol. 8, 523–532 (2008).
  CAS Google Scholar
• Krummel, M. F. & Allison, J. P. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med. 183, 2533–2540 (1996).
  CAS PubMed Google Scholar
• Walunas, T. L., Bakker, C. Y. & Bluestone, J. A. CTLA-4 ligation blocks CD28-dependent T cell activation. J. Exp. Med. 183, 2541–2550 (1996).
  CAS PubMed Google Scholar
• Chuang, E. et al. The CD28 and CTLA-4 receptors associate with the serine/threonine phosphatase PP2A. Immunity 13, 313–322 (2000).
  CAS PubMed Google Scholar
• Parry, R. V. et al. CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Mol. Cell. Biol. 25, 9543–9553 (2005).
  CAS PubMed PubMed Central Google Scholar
• Marengere, L. E. et al. Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4. Science 272, 1170–1173 (1996).
  CAS PubMed Google Scholar
• Lee, K. M. et al. Molecular basis of T cell inactivation by CTLA-4. Science 282, 2263–2266 (1998).
  CAS PubMed Google Scholar
• Martin, M., Schneider, H., Azouz, A. & Rudd, C. E. Cytotoxic T lymphocyte antigen 4 and CD28 modulate cell surface raft expression in their regulation of T cell function. J. Exp. Med. 194, 1675–1681 (2001).
  CAS PubMed PubMed Central Google Scholar
• Chikuma, S., Imboden, J. B. & Bluestone, J. A. Negative regulation of T cell receptor-lipid raft interaction by cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 197, 129–135 (2003).
  CAS PubMed PubMed Central Google Scholar
• Darlington, P. J. et al. Surface cytotoxic T lymphocyte-associated antigen 4 partitions within lipid rafts and relocates to the immunological synapse under conditions of inhibition of T cell activation. J. Exp. Med. 195, 1337–1347 (2002).
  CAS PubMed PubMed Central Google Scholar
• Chuang, E. et al. Regulation of cytotoxic T lymphocyte-associated molecule-4 by Src kinases. J. Immunol. 162, 1270–1277 (1999).
  CAS PubMed Google Scholar
• Hu, H., Rudd, C. E. & Schneider, H. Src kinases Fyn and Lck facilitate the accumulation of phosphorylated CTLA-4 and its association with PI-3 kinase in intracellular compartments of T-cells. Biochem. Biophys. Res. Commun. 288, 573–578 (2001).
  CAS PubMed Google Scholar
• Schneider, H., Schwartzberg, P. L. & Rudd, C. E. Resting lymphocyte kinase (Rlk/Txk) phosphorylates the YVKM motif and regulates PI 3-kinase binding to T-cell antigen CTLA-4. Biochem. Biophys. Res. Commun. 252, 14–19 (1998).
  CAS PubMed Google Scholar
• Schneider, H., Valk, E., Leung, R. & Rudd, C. E. CTLA-4 activation of phosphatidylinositol 3-kinase (PI 3-K) and protein kinase B (PKB/AKT) sustains T-cell anergy without cell death. PLoS ONE 3, e3842 (2008).
  PubMed PubMed Central Google Scholar
• Schneider, H. et al. Cutting edge: CTLA-4 (CD152) differentially regulates mitogen-activated protein kinases (extracellular signal-regulated kinase and c-Jun N-terminal kinase) in CD4+ T cells from receptor/ligand-deficient mice. J. Immunol. 169, 3475–3479 (2002).
  CAS PubMed Google Scholar
• Schneider, H., Smith, X., Liu, H., Bismuth, G. & Rudd, C. E. CTLA-4 disrupts ZAP70 microcluster formation with reduced T cell/APC dwell times and calcium mobilization. Eur. J. Immunol. 38, 40–47 (2008).
  CAS PubMed PubMed Central Google Scholar
• Calvo, C. R., Amsen, D. & Kruisbeek, A. M. Cytotoxic T lymphocyte antigen 4 (CTLA-4) interferes with extracellular signal-regulated kinase (ERK) and Jun NH2-terminal kinase (JNK) activation, but does not affect phosphorylation of T cell receptor ζ and ZAP70. J. Exp. Med. 186, 1645–1653 (1997).
  CAS PubMed PubMed Central Google Scholar
• Stein, P. H., Fraser, J. D. & Weiss, A. The cytoplasmic domain of CD28 is both necessary and sufficient for costimulation of interleukin-2 secretion and association with phosphatidylinositol 3′-kinase. Mol. Cell. Biol. 14, 3392–3402 (1994).
  CAS PubMed PubMed Central Google Scholar
• Araki, M. et al. Genetic evidence that the differential expression of the ligand-independent isoform of CTLA-4 is the molecular basis of the Idd5.1 type 1 diabetes region in nonobese diabetic mice. J. Immunol. 183, 5146–5157 (2009).
  CAS PubMed Google Scholar
• Chikuma, S., Abbas, A. K. & Bluestone, J. A. B7-independent inhibition of T cells by CTLA-4. J. Immunol. 175, 177–181 (2005).
  CAS PubMed Google Scholar
• Choi, J. M. et al. Transduction of the cytoplasmic domain of CTLA-4 inhibits TcR-specific activation signals and prevents collagen-induced arthritis. Proc. Natl Acad. Sci. USA 105, 19875–19880 (2008).
  CAS PubMed PubMed Central Google Scholar
• Choi, J. M. et al. Intranasal delivery of the cytoplasmic domain of CTLA-4 using a novel protein transduction domain prevents allergic inflammation. Nature Med. 12, 574–579 (2006).
  CAS PubMed Google Scholar
• Jeffery, L. et al. 1,25-dihydroxyvitamin D3 and interleukin-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J. Immunol. 183, 5458–5467 (2009).
  CAS PubMed Google Scholar
• Bowlus, C. L. The role of iron in T cell development and autoimmunity. Autoimmun. Rev. 2, 73–78 (2003).
  CAS PubMed Google Scholar
• Thompson, C. B. & Allison, J. P. The emerging role of CTLA-4 as an immune attenuator. Immunity 7, 445–450 (1997).
  CAS PubMed Google Scholar
• Alegre, M.-L. et al. Regulation of surface and intracellular expression of CTLA-4 on mouse T cells. J. Immunol. 157, 4762–4770 (1996).
  CAS PubMed Google Scholar
• Carreno, B. M. et al. CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression. J. Immunol. 165, 1352–1356 (2000).
  CAS PubMed Google Scholar
• Yokosuka, T. et al. Spatiotemporal basis of CTLA-4 costimulatory molecule-mediated negative regulation of T cell activation. Immunity 33, 326–339 (2010).
  CAS PubMed Google Scholar
• Masteller, E. L., Chuang, E., Mullen, A. C., Reiner, S. L. & Thompson, C. B. Structural analysis of CTLA-4 function in vivo. J. Immunol. 164, 5319–5327 (2000).
  CAS PubMed Google Scholar
• Schneider, H., Valk, E., da Rocha Dias, S., Wei, B. & Rudd, C. E. CTLA-4 up-regulation of lymphocyte function-associated antigen 1 adhesion and clustering as an alternate basis for coreceptor function. Proc. Natl Acad. Sci. USA 102, 12861–12866 (2005).
  CAS PubMed PubMed Central Google Scholar
• Onishi, Y., Fehervari, Z., Yamaguchi, T. & Sakaguchi, S. Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc. Natl Acad. Sci. USA 105, 10113–10118 (2008).
  CAS PubMed PubMed Central Google Scholar
• Schneider, H. et al. Reversal of the TCR stop signal by CTLA-4. Science 313, 1972–1975 (2006).
  CAS PubMed Google Scholar
• Downey, J., Smith, A., Schneider, H., Hogg, N. & Rudd, C. E. TCR/CD3 mediated stop-signal is decoupled in T-cells from Ctla4 deficient mice. Immunol. Lett. 115, 70–72 (2008).
  CAS PubMed Google Scholar
• Tang, Q. et al. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nature Immunol. 7, 83–92 (2006).
  CAS Google Scholar
• Fife, B. T. et al. Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal. Nature Immunol. 10, 1185–1192 (2009).
  CAS Google Scholar
• Bachmann, M. F., Kohler, G., Ecabert, B., Mak, T. W. & Kopf, M. Cutting edge: lymphoproliferative disease in the absence of CTLA-4 is not T cell autonomous. J. Immunol. 163, 1128–1131 (1999). This seminal paper showed for the first time that CTLA4-deficient cells are controlled by a cohort of CTLA4-sufficient cells in mixed bone marrow chimaeras. Despite its relative under-appreciation, this represents the most reproducible experimental approach in CTLA4 biology.
  CAS PubMed Google Scholar
• Homann, D. et al. Lack of intrinsic CTLA-4 expression has minimal effect on regulation of antiviral T-cell immunity. J. Virol. 80, 270–280 (2006). A careful and comprehensive study of the responses of CTLA4-deficient and CTLA4-sufficient T cells in mixed bone marrow chimaeras. The study examined T cell proliferation, effector function, repertoire selection, functional avidity and memory.
  CAS PubMed PubMed Central Google Scholar
• Chikuma, S. & Bluestone, J. A. Expression of CTLA-4 and FOXP3 in cis protects from lethal lymphoproliferative disease. Eur. J. Immunol. 37, 1285–1289 (2007).
  CAS PubMed Google Scholar
• Friedline, R. H. et al. CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance. J. Exp. Med. 206, 421–434 (2009).
  CAS PubMed PubMed Central Google Scholar
• Tivol, E. A. & Gorski, J. Re-establishing peripheral tolerance in the absence of CTLA-4: complementation by wild-type T cells points to an indirect role for CTLA-4. J. Immunol. 169, 1852–1858 (2002).
  CAS PubMed Google Scholar
• Bachmann, M. F. et al. Normal pathogen-specific immune responses mounted by CTLA-4-deficient T cells: a paradigm reconsidered. Eur. J. Immunol. 31, 450–458 (2001).
  CAS PubMed Google Scholar
• Bachmann, M. F. et al. Normal responsiveness of CTLA-4-deficient anti-viral cytotoxic T cells. J. Immunol. 160, 95–100 (1998).
  CAS PubMed Google Scholar
• Grohmann, U. et al. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nature Immunol. 3, 1097–1101 (2002).
  CAS Google Scholar
• Fallarino, F. et al. Modulation of tryptophan catabolism by regulatory T cells. Nature Immunol. 4, 1206–1212 (2003).
  CAS Google Scholar
• Munn, D. H. et al. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J. Exp. Med. 189, 1363–1372 (1999).
  CAS PubMed PubMed Central Google Scholar
• Mellor, A. L. et al. Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase. Int. Immunol. 16, 1391–1401 (2004).
  CAS PubMed Google Scholar
• Orabona, C. et al. CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86. Nature Immunol. 5, 1134–1142 (2004).
  CAS Google Scholar
• Munn, D. H., Sharma, M. D. & Mellor, A. L. Ligation of B7–1/B7–2 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells. J. Immunol. 172, 4100–4110 (2004).
  CAS PubMed Google Scholar
• Walker, L. S. et al. Compromised OX40 function in CD28-deficient mice is linked with failure to develop CXC chemokine receptor 5-positive CD4 cells and germinal centers. J. Exp. Med. 190, 1115–1122 (1999).
  CAS PubMed PubMed Central Google Scholar
• Manches, O. et al. HIV-activated human plasmacytoid DCs induce Tregs through an indoleamine 2,3-dioxygenase-dependent mechanism. J. Clin. Invest. 118, 3431–3439 (2008).
  CAS PubMed PubMed Central Google Scholar
• Davis, P. M., Nadler, S. G., Stetsko, D. K. & Suchard, S. J. Abatacept modulates human dendritic cell-stimulated T-cell proliferation and effector function independent of IDO induction. Clin. Immunol. 126, 38–47 (2008).
  CAS PubMed Google Scholar
• Agaugue, S., Perrin-Cocon, L., Coutant, F., Andre, P. & Lotteau, V. 1-Methyl-tryptophan can interfere with TLR signaling in dendritic cells independently of IDO activity. J. Immunol. 177, 2061–2071 (2006).
  CAS PubMed Google Scholar
• Chen, W., Jin, W. & Wahl, S. M. Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor β (TGF-β) production by murine CD4+ T cells. J. Exp. Med. 188, 1849–1857 (1998).
  CAS PubMed PubMed Central Google Scholar
• Oida, T., Xu, L., Weiner, H. L., Kitani, A. & Strober, W. TGF-β-mediated suppression by CD4+CD25+ T cells is facilitated by CTLA-4 signaling. J. Immunol. 177, 2331–2339 (2006).
  CAS PubMed Google Scholar
• Sullivan, T. J. et al. Lack of a role for transforming growth factor-β in cytotoxic T lymphocyte antigen-4-mediated inhibition of T cell activation. Proc. Natl Acad. Sci. USA 98, 2587–2592 (2001).
  CAS PubMed PubMed Central Google Scholar
• Green, E. A., Gorelik, L., McGregor, C. M., Tran, E. H. & Flavell, R. A. CD4+CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-β–TGF-β receptor interactions in type 1 diabetes. Proc. Natl Acad. Sci. USA 100, 10878–10883 (2003).
  CAS PubMed PubMed Central Google Scholar
• Fahlen, L. et al. T cells that cannot respond to TGF-β escape control by CD4+CD25+ regulatory T cells. J. Exp. Med. 201, 737–746 (2005).
  CAS PubMed PubMed Central Google Scholar
• Shull, M. M. et al. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359, 693–699 (1992).
  CAS PubMed PubMed Central Google Scholar
• Magistrelli, G. et al. A soluble form of CTLA-4 generated by alternative splicing is expressed by nonstimulated human T cells. Eur. J. Immunol. 29, 3596–3602 (1999).
  CAS PubMed Google Scholar
• Oaks, M. K. & Hallett, K. M. Cutting edge: a soluble form of CTLA-4 in patients with autoimmune thyroid disease. J. Immunol. 164, 5015–5018 (2000).
  CAS PubMed Google Scholar
• Toussirot, E. et al. Increased production of soluble CTLA-4 in patients with spondylarthropathies correlates with disease activity. Arthritis Res. Ther. 11, R101 (2009).
  PubMed PubMed Central Google Scholar
• Purohit, S. et al. Lack of correlation between the levels of soluble cytotoxic T-lymphocyte associated antigen-4 (CTLA-4) and the CT-60 genotypes. J. Autoimmune Dis. 2, 8 (2005).
  PubMed PubMed Central Google Scholar
• Mayans, S. et al. CT60 genotype does not affect CTLA-4 isoform expression despite association to T1D and AITD in northern Sweden. BMC Med. Genet. 8, 3 (2007).
  PubMed PubMed Central Google Scholar
• Berry, A., Tector, M. & Oaks, M. K. Lack of association between sCTLA-4 levels in human plasma and common CTLA-4 polymorphisms. J. Negat. Results Biomed. 7, 8 (2008).
  PubMed PubMed Central Google Scholar
• Tector, M., Khatri, B. O., Kozinski, K., Dennert, K. & Oaks, M. K. Biochemical analysis of CTLA-4 immunoreactive material from human blood. BMC Immunol. 10, 51 (2009).
  PubMed PubMed Central Google Scholar
• Tadokoro, C. E. et al. Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo. J. Exp. Med. 203, 505–511 (2006).
  CAS PubMed PubMed Central Google Scholar
• Misra, N., Bayry, J., Lacroix-Desmazes, S., Kazatchkine, M. D. & Kaveri, S. V. Cutting edge: human CD4+CD25+ T cells restrain the maturation and antigen-presenting function of dendritic cells. J. Immunol. 172, 4676–4680 (2004).
  CAS PubMed Google Scholar
• Cederbom, L., Hall, H. & Ivars, F. CD4+CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur. J. Immunol. 30, 1538–1543 (2000).
  CAS PubMed Google Scholar
• Kastenmuller, W. et al. Regulatory T cells selectively control CD8+ T cell effector pool size via IL-2 restriction. J. Immunol. 187, 3186–3197 (2011).
  CAS PubMed Google Scholar
• Oderup, C., Cederbom, L., Makowska, A., Cilio, C. M. & Ivars, F. Cytotoxic T lymphocyte antigen-4-dependent down-modulation of costimulatory molecules on dendritic cells in CD4+ CD25+ regulatory T-cell-mediated suppression. Immunology 118, 240–249 (2006).
  CAS PubMed PubMed Central Google Scholar
• Schildknecht, A. et al. FoxP3+ regulatory T cells essentially contribute to peripheral CD8+ T-cell tolerance induced by steady-state dendritic cells. Proc. Natl Acad. Sci. USA 107, 199–203 (2010).
  CAS PubMed Google Scholar
• Serra, P. et al. CD40 ligation releases immature dendritic cells from the control of regulatory CD4+CD25+ T cells. Immunity 19, 877–889 (2003).
  CAS PubMed Google Scholar
• Kusakari, S. et al. Trans-endocytosis of CD47 and SHPS-1 and its role in regulation of the CD47–SHPS-1 system. J. Cell Sci. 121, 1213–1223 (2008).
  CAS PubMed Google Scholar
• Marston, D. J., Dickinson, S. & Nobes, C. D. Rac-dependent trans-endocytosis of ephrinBs regulates Eph–ephrin contact repulsion. Nature Cell Biol. 5, 879–888 (2003).
  CAS PubMed Google Scholar
• Cagan, R. L., Kramer, H., Hart, A. C. & Zipursky, S. L. The bride of sevenless and sevenless interaction: internalization of a transmembrane ligand. Cell 69, 393–399 (1992).
  CAS PubMed Google Scholar
• Davis, D. M. Intercellular transfer of cell-surface proteins is common and can affect many stages of an immune response. Nature Rev. Immunol. 7, 238–243 (2007).
  CAS Google Scholar
• Greenwald, R. J., Boussiotis, V. A., Lorsbach, R. B., Abbas, A. K. & Sharpe, A. H. CTLA-4 regulates induction of anergy in vivo. Immunity 14, 145–155 (2001).
  CAS PubMed Google Scholar
• Eggena, M. P. et al. Cooperative roles of CTLA-4 and regulatory T cells in tolerance to an islet cell antigen. J. Exp. Med. 199, 1725–1730 (2004).
  CAS PubMed PubMed Central Google Scholar
• Walker, L. S., Ausubel, L. J., Chodos, A., Bekarian, N. & Abbas, A. K. CTLA-4 differentially regulates T cell responses to endogenous tissue protein versus exogenous immunogen. J. Immunol. 169, 6202–6209 (2002).
  CAS PubMed Google Scholar
• Bernard, D. et al. Costimulatory receptors in a teleost fish: typical CD28, elusive CTLA4. J. Immunol. 176, 4191–4200 (2006).
  CAS PubMed Google Scholar
• Hansen, J. D. et al. The B7 family of immunoregulatory receptors: a comparative and evolutionary perspective. Mol. Immunol. 46, 457–472 (2009).
  CAS PubMed Google Scholar
• Chambers, C. A., Cado, D., Truong, T. & Allison, J. P. Thymocyte development is normal in CTLA-4-deficient mice. Proc. Natl Acad. Sci. USA 94, 9296–9301 (1997).
  CAS PubMed PubMed Central Google Scholar
• Tang, A. L. et al. CTLA4 expression is an indicator and regulator of steady-state CD4+ FoxP3+ T cell homeostasis. J. Immunol. 181, 1806–1813 (2008).
  CAS PubMed Google Scholar
• Salomon, B. et al. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12, 431–440 (2000).
  CAS PubMed Google Scholar
• Ikemizu, S. et al. Structure and dimerization of a soluble form of B7–1. Immunity 12, 51–60 (2000).
  CAS PubMed Google Scholar
• Catalfamo, M., Tai, X., Karpova, T., McNally, J. & Henkart, P. A. TcR-induced regulated secretion leads to surface expression of CTLA-4 in CD4+CD25+ T cells. Immunology 125, 70–79 (2008).
  CAS PubMed PubMed Central Google Scholar
• Rudd, C. E. The reverse stop-signal model for CTLA4 function. Nature Rev. Immunol. 8, 153–160 (2008).
  CAS Google Scholar